Truepill

How it happened

Truepill is a digital pharmacy and healthcare-fulfillment platform powering prescription delivery, telehealth and testing for other brands. A $142M Series D in October 2021 pushed its valuation to $1.6B and unicorn status. As growth funding dried up, Truepill ran four rounds of layoffs in 2022, refocused on its core pharmacy business, raised a $66M insider round in August 2023, then sold to LetsGetChecked for $525M in August 2024 — about 67% below peak. Glassdoor reviews corroborate the churn: employees counted those same four rounds, describing a hiring spree that reversed into cuts often made by email and priorities that shifted every few weeks, with some later crediting a new CEO for steadying the business.

Employee accounts paraphrase anonymous, unverified reviews posted publicly on Glassdoor ↗. See our methodology.